Table 1.
Clinical and MRI findings in 5 patients with NIID identified from PACS.
|
33.8-1.55,15.5Patient number/sex/age (year) |
Initial clinical assessment | Final diagnosis |
Onset symptoms |
Family history |
Location of DWI hyperintensity |
Fazekas grade |
Hyperintensity on T2/FLAIR images |
|---|---|---|---|---|---|---|---|
| 1/M/54 | NIID | NIID | Episodic encephalopathy | + | F, P, T, O | 3 | F, P, T, O BG, CC BS, MCP, C |
| 2/F/63 | NIID | NIID | Cognitive impairment | – | F | 2 | F, P, T, O CC |
| 3/F/60 | NIID | NIID | Episodic encephalopathy | – | F, P, T | 2 | F, P, T, O CC |
| 4/F/63 | Myopathy | NIID | Muscular weakness | – | F, P, T, O BG, CC BS, MCP |
3 | F, P, T, O BG, CC BS, MCP, C |
| 5/F/78 | NPH | NIID | Urinary incontinence | + | F, P, T, O BG, CC BS |
3 | F, P, T, O BG, CC BS, C |
F, frontal; P, parietal; T, temporal; O, occipital; BG, basal ganglion; CC, corpus callosum; BS, brainstem; MCP, middle cerebellar peduncle; C, cerebellum.